Amandala Neuro

🗓 Founded 2025👥 8 employees💰 Last funded Jan 2026
Biotechnology Research🌐 amandalaneuro.com
Website LinkedIn
We are a clinical-stage biopharmaceutical company spun out of the strategic combination of Beckley Psytech and Atai Life Sciences in 2025, advancing lead asset ELE-101. We develop patient-centered psychedelic treatments designed to fit the psychiatric care model and address unmet need in mental health.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2025
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Amandala Neuro?
Amandala Neuro has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Amandala Neuro last raise funding?
The most recent investment in Amandala Neuro recorded on gritt.io was in January 2026.
When was Amandala Neuro founded?
Amandala Neuro was founded in 2025.
What industry is Amandala Neuro in?
Amandala Neuro operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.